Tamoxifen Administration in Transgenic Mice-Ding Lab

Output Details

This protocol describes the procedure for inducing CreER-mediated recombination at loxP sites in transgenic mice through the administration of tamoxifen or 4-hydroxytamoxifen (4-OHT).
Tags
  • Animal
  • Animal models
  • Genetic models
  • In Vivo
  • Mouse

Meet the Authors

  • User avatar fallback logo

    Yue Sun, PhD

    Key Personnel: Team Surmeier

    Stanford University

  • User avatar fallback logo

    Richard Roth, PhD

    Key Personnel: Team Surmeier

    Stanford University

  • User avatar fallback logo

    Fuu Jiun Hwang, PhD

    Key Personnel: Team Surmeier

    Stanford University

  • User avatar fallback logo

    Jun Ding, PhD

    Collaborating PI: Team Surmeier

    Stanford University